Am J Transplant, Volume 18, Suppl 3 Archives - Page 195 of 211 - ATC Abstracts

2018 American Transplant Congress
Should Kidneys from Donation after Cardiac Death Expanded Criteria Donors Be Transplanted?
D. Harriman, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, M. Gautreaux, W. Doares, S. Kaczmorski, R. Stratta.
Surgery, Medicine, Pathology, Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Introduction: Expanded criteria donor (ECD) kidneys increase the organ pool but their discard rate remains high, especially in the setting of donation after cardiac death…
2018 American Transplant Congress
A Meta-Analysis for Induction Therapy of Kidney Transplantation: Comparison of Antithymocyte Globulin and Interleukin 2 Receptor Antagonist
G. Chen, Z. Wu, C. Wang, X. Liu, C. Wang, L. Chen.
Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Objectives To compare the efficacy and safety of antithymocyte globulin (ATG) and interleukin 2 receptor antagonist (IL2Ra) in induction therapy of kidney transplantation.Method A literature…
2018 American Transplant Congress
Developing a Rationale for an Appropriate Immunosuppressive Regimen in Lung vs Kidney Transplant Recipients: Effects of Induction Therapy
P. Martin-Moreno,^1,2 H. Shin,^1,3 H. Goldberg,⁴ A. Chandraker.¹
¹Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; ²Nephrology Department, Clinica Universidad de Navarra, Pamplona, Spain; ³Renal Division, Department of Internal Medicine, Gospel Hospital, Kosin University College of Medicine, Busan, Korea; ⁴Pulmonary Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
IntroductionThe appropriate use of Thymoglobulin (ATG) or Basiliximab as induction therapy is not fully understood. We studied circulating cytokine profiles following kidney and lung transplantation…
2018 American Transplant Congress
Long-Term Renal Function in Living Kidney Donors with Renal Cysts
M. Waldram, A. Thomas, A. Muzaale, C. Holscher, A. Nguyen, S. Halpern, S. Anjum, J. Alejo, B. Boyarsky, S. Ottman, J. Garonzik-Wang, D. Segev, A. Massie.
JHU, Baltimore.
Renal cysts found during the evaluation of living kidney donor (LKD) candidates are often regarded as benign. However, it is possible that these structural abnormalities…
2018 American Transplant Congress
Objective Markers of Frailty Predict Successful Listing and Survival for Renal Transplant
A. Tevar, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, M. Molinari, A. Humar, Y. Wang, J. Steel.
Surgery, University of Pittsburgh, Pittsburgh, PA.
Background: Across all medical specialties, frailty has been shown to be a predictor of poor health outcomes. Previous studies have shown that gait speed and…
2018 American Transplant Congress
Validation of Edmonton Symptom Assessment Survey in Kidney Transplant Recipients (KTR)
M. Pokarowski, S. Dano, A. Albdalla, M. Khalid, O. Ekundayo, Y. Liao, N. Edwards, I. Mucsi.
Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada.
Background: Patient-reported outcomes provide important information about symptom and illness experience of patients with chronic medical conditions. The Edmonton Symptom Assessment System (ESAS) is a…
2018 American Transplant Congress
Greater Susceptibility for Metabolic Syndrome in Pediatric Transplant Recipients – A Case-Control Study
R. Bloete,¹ N. Memaran,¹ B. Borchert-Mörlins,¹ D. Thurn,¹ E. Bauer,¹ R. Büscher,² J. Oh,³ B. Schmidt,⁴ A. Melk.¹
¹Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Hanover, Germany; ²Department of Pediatric Nephrology, University Hospital Essen, Essen, Germany; ³Department of Pediatric Nephrology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; ⁴Department of Nephrology, Hannover Medical School, Hanover, Germany.
Introduction. Metabolic syndrome not only contributes to an increased risk for cardiovascular sequelae but is also associated with impaired graft function and lower graft survival…
2018 American Transplant Congress
Disparities in Re-Transplantation among Pediatric Renal Transplant Recipients with Graft Failure
M. Basu,¹ R. Patzer,¹ R. George.^1,2
¹Emory University School of Medicine, Atlanta, GA; ²Pediatric Nephrology, Children's Healthcare of Atlanta, Atlanta, GA.
Background: While gender and racial disparities in access to transplantation have been reported among pediatric patients, few studies have investigated if these disparities exist in…
2018 American Transplant Congress
Immunoglobulin Replacement Therapy in Pediatric Renal Transplant Patients
A. Lewis, M. Fasano, D. Zepeda-Orozco.
University of Iowa Hospitals and Clinics, Iowa City, IA.
Immunoglobulin replacement therapy decreases infection frequency in patients with primary immunodeficiency; however, there is limited data regarding the use of intravenous immunoglobulin (IVIG) or subcutaneous…
2018 American Transplant Congress
Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis
A. Humar,¹ P. Liu,² J. Luo,³ M. Nalesnik,³ A. Singhi,³ G. Tseng,² G. Michalopoulos.³
¹Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA; ²Biostatistics, University of Pittsburgh, Pittsburgh, PA; ³Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA.
Liver allocation for transplant candidates with hepatocellular carcinoma is limited by OPTN policy to patients whose tumors remain within size limits defined by Milan criteria.…